Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 33

1.

Emergent versus urgent ERCP in acute cholangitis: a systematic review and meta-analysis.

Iqbal U, Khara HS, Hu Y, Khan MA, Ovalle A, Siddique O, Sun H, Shellenberger MJ.

Gastrointest Endosc. 2019 Oct 16. pii: S0016-5107(19)32318-1. doi: 10.1016/j.gie.2019.09.040. [Epub ahead of print] Review.

PMID:
31628955
2.

Suboptimal Use of Inpatient Palliative Care Consultation May Lead to Higher Readmissions and Costs in End-Stage Liver Disease.

Adejumo AC, Kim D, Iqbal U, Yoo ER, Boursiquot BC, Cholankeril G, Wong RJ, Kwo PY, Ahmed A.

J Palliat Med. 2019 Aug 9. doi: 10.1089/jpm.2019.0100. [Epub ahead of print]

PMID:
31397615
3.

Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study.

Adejumo AC, Cholankeril G, Iqbal U, Yoo ER, Boursiquot BC, Concepcion WC, Kim D, Ahmed A.

Dig Dis Sci. 2019 Aug 1. doi: 10.1007/s10620-019-05759-4. [Epub ahead of print]

PMID:
31372912
4.

Treatment of inoperable hepatocellular carcinoma with immunotherapy.

Tighe SP, Iqbal U, Fernandes CT, Ahmed A.

BMJ Case Rep. 2019 Jul 27;12(7). pii: e229744. doi: 10.1136/bcr-2019-229744.

PMID:
31352386
5.

Acute Pancreatitis Secondary to Use of Appetite Suppressant: Garcinia cambogia.

Iqbal U, Anwar H, Siddiqui HU, Mehmood A.

Cureus. 2019 May 16;11(5):e4676. doi: 10.7759/cureus.4676.

6.

Trends in Mortality From Extrahepatic Complications in Patients With Chronic Liver Disease, From 2007 Through 2017.

Kim D, Adejumo AC, Yoo ER, Iqbal U, Li AA, Pham EA, Cholankeril G, Glenn JS, Ahmed A.

Gastroenterology. 2019 Oct;157(4):1055-1066.e11. doi: 10.1053/j.gastro.2019.06.026. Epub 2019 Jun 25.

PMID:
31251928
7.

Kratom-Induced Cholestatic Liver Injury and Its Conservative Management.

Fernandes CT, Iqbal U, Tighe SP, Ahmed A.

J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619836138. doi: 10.1177/2324709619836138.

8.

The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease.

Iqbal U, Perumpail BJ, Akhtar D, Kim D, Ahmed A.

Medicines (Basel). 2019 Mar 18;6(1). pii: E41. doi: 10.3390/medicines6010041. Review.

9.

Use of anti-platelet agents in the prevention of hepatic fibrosis in patients at risk for chronic liver disease: a systematic review and meta-analysis.

Iqbal U, Dennis BB, Li AA, Cholankeril G, Kim D, Khan MA, Ahmed A.

Hepatol Int. 2019 Jan;13(1):84-90. doi: 10.1007/s12072-018-9918-2. Epub 2018 Dec 12.

10.

Use of Curcumin in Achieving Clinical and Endoscopic Remission in Ulcerative Colitis: A Systematic Review and Meta-analysis.

Iqbal U, Anwar H, Quadri AA.

Am J Med Sci. 2018 Oct;356(4):350-356. doi: 10.1016/j.amjms.2018.06.023.

PMID:
30360803
11.

Microscopic colitis: Diarrhoea or constipation.

Iqbal U, Anwar H.

J Pak Med Assoc. 2018 Jun;68(6):972. No abstract available.

12.

Proton Pump Inhibitors (PPIs) are inhibitors or risk factor for Atrial Fibrillation?

Iqbal U, Anwar H.

J Pak Med Assoc. 2018 Jul;68(7):1141. No abstract available.

13.

Anti-Diabetic Medications for the Pharmacologic Management of NAFLD.

Cholankeril R, Patel V, Perumpail BJ, Yoo ER, Iqbal U, Sallam S, Shah ND, Kwong W, Kim D, Ahmed A.

Diseases. 2018 Oct 3;6(4). pii: E93. doi: 10.3390/diseases6040093. Review.

14.

When to Initiate Weight Loss Medications in the NAFLD Population.

Yoo ER, Sallam S, Perumpail BJ, Iqbal U, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A.

Diseases. 2018 Sep 30;6(4). pii: E91. doi: 10.3390/diseases6040091. Review.

15.

Judicious Use of Lipid Lowering Agents in the Management of NAFLD.

Iqbal U, Perumpail BJ, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A.

Diseases. 2018 Sep 24;6(4). pii: E87. doi: 10.3390/diseases6040087. Review.

16.

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD.

Perumpail BJ, Li AA, Iqbal U, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A.

Diseases. 2018 Sep 10;6(3). pii: E80. doi: 10.3390/diseases6030080. Review.

17.

Safety and efficacy of a minimally invasive cell sampling device ('Cytosponge') in the diagnosis of esophageal pathology: a systematic review.

Iqbal U, Siddique O, Ovalle A, Anwar H, Moss SF.

Eur J Gastroenterol Hepatol. 2018 Nov;30(11):1261-1269. doi: 10.1097/MEG.0000000000001210.

PMID:
30044236
18.

The Role of Cannabinoids in the Setting of Cirrhosis.

Dibba P, Li AA, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A.

Medicines (Basel). 2018 Jun 9;5(2). pii: E52. doi: 10.3390/medicines5020052. Review.

19.

Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease.

Dibba P, Li A, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A.

Medicines (Basel). 2018 May 28;5(2). pii: E47. doi: 10.3390/medicines5020047. Review.

20.

Ringer's lactate versus normal saline in acute pancreatitis: A systematic review and meta-analysis.

Iqbal U, Anwar H, Scribani M.

J Dig Dis. 2018 Jun;19(6):335-341. doi: 10.1111/1751-2980.12606. Epub 2018 Jun 10. Review.

PMID:
29732686

Supplemental Content

Loading ...
Support Center